Dublin based healthcare company Alltracel has announced a joint venture with a UK distributor to market its wound treatment products.
Omscan, headed up by Nigel Theobald and Nigel Bathurst, former senior marketing executives at Boots will market Alltracel's m.doc wound treatments to the the UK professional healthcare sector.
Omscan will exclusively license the Seal-On brand name from Alltracel within the UK and launch it as a range of professional products for sale in the NHS and other primary health care sectors.
The existing range of Seal-On consumer products will remain on sale throughout the UK and this channel will also be managed by Omscan.
Alltracel are taking a 20 per cent equity stake in Omscan in return for an initial product stock transfer, and will work closely with the Omscan team on professional sector product and packaging development.